Janus Henderson Group PLC Boosts Stock Holdings in CME Group Inc. (NASDAQ:CME)

Janus Henderson Group PLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 17.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,514,040 shares of the financial services provider’s stock after purchasing an additional 380,071 shares during the quarter. Janus Henderson Group PLC owned approximately 0.70% of CME Group worth $554,707,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Truvestments Capital LLC purchased a new stake in CME Group in the 3rd quarter worth $26,000. Y.D. More Investments Ltd purchased a new stake in CME Group in the 2nd quarter worth $36,000. McClarren Financial Advisors Inc. increased its holdings in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC increased its holdings in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its holdings in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 1.57 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 5.38 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,028 shares of company stock worth $1,811,681 in the last 90 days. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Down 1.0 %

Shares of CME stock opened at $235.61 on Tuesday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $238.97. The company has a 50 day moving average price of $225.55 and a 200 day moving average price of $211.96. The stock has a market capitalization of $84.90 billion, a P/E ratio of 24.77, a price-to-earnings-growth ratio of 5.49 and a beta of 0.56. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $2.25 EPS. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. Equities research analysts predict that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 1.95%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is currently 48.37%.

Analyst Ratings Changes

CME has been the subject of several recent analyst reports. TD Cowen initiated coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Barclays lifted their target price on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Finally, Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.